首页> 外文期刊>Current opinion in pharmacology >New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery
【24h】

New developments in the pharmacological modulation of wound healing after glaucoma filtration surgery

机译:青光眼滤过术后伤口愈合的药理学调节新进展

获取原文
获取原文并翻译 | 示例
       

摘要

Despite the advent of many new devices for glaucoma surgery, scarring is the main cause of suboptimal pressure control and surgical failure in all forms of surgery. The cytotoxic antimetabolites, 5-flurouracil and mitomycin C both prolong success but with the increased risk of blinding complications. A greater understanding of the cellular mechanisms of the wound healing response has led to the identification and modulation of potential therapeutic targets. These include transforming factor ??, inflammatory mediators, the acute phase protein serum amyloid P, vascular endothelial growth factor and the matrix metallaproteinases. While optimal drug delivery is still a major challenge, modulating these effects either directly or through downstream signalling promises to yield anti-scarring efficacy, while minimising side effects. ? 2012 Elsevier Ltd.
机译:尽管出现了许多用于青光眼手术的新设备,但疤痕形成是所有形式手术中压力控制不足和手术失败的主要原因。具有细胞毒性的抗代谢物,5-氟尿嘧啶和丝裂霉素C均可延长成功时间,但增加致盲并发症的风险。对伤口愈合反应的细胞机制的更深入的了解导致了潜在治疗靶标的鉴定和调节。这些包括转化因子α1,炎性介质,急性期蛋白血清淀粉样蛋白P,血管内皮生长因子和基质金属蛋白酶。尽管最佳药物递送仍然是一个主要挑战,但是直接或通过下游信号传导调节这些作用有望产生抗瘢痕形成的功效,同时将副作用降至最低。 ? 2012爱思唯尔有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号